Story · Medicine & Biotech
Dapagliflozin Metformin in T2D: Five Evidence Insights Relevant for Clinicians
1 outlet · first reported by Medical Dialogues on
Diabetes affects an estimated 589 million adults worldwide, nearly one in nine, and is projected to reach 853 million by 2050. 1 Yet, T2D rarely presents in isolation: the same diagnosis may coexist with obesity, fatty liver disease, cardiorenal risk, or age-related bone loss, each reshaping… (Medical Dialogues)
Coverage, in order
-
Dapagliflozin Metformin in T2D: Five Evidence Insights Relevant for CliniciansDiabetes affects an estimated 589 million adults worldwide, nearly one in nine, and is projected to reach 853 million by 2050. 1 Yet, T2D rarely presents in isolation: the same diagnosis may coexist with obesity, fatty liver disease, cardiorenal risk, or age-related bone loss, each reshaping…
Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.